Pasithea Therapeutics (KTTA) Receivables - Net (2022 - 2025)
Pasithea Therapeutics' (KTTA) quarterly Receivables - Net came in at $43000.0 in Q4 2025, little changed quarter-over-quarter from $43000.0 in Q1 2025.
Pasithea Therapeutics (KTTA) Receivables - Net (2022 - 2025) Analysis & Trends
Pasithea Therapeutics has disclosed Receivables - Net across 2 years of filings, most recently posting $43000.0 for Q4 2025.
- Receivables - Net for Q4 2025 came in at $43000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $43000.0 (changed N/A YoY), and the FY2025 annual result was $43000.0, changed N/A from the prior year.
- Receivables - Net came in at $43000.0 for Q4 2025 at Pasithea Therapeutics, roughly flat from $43000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $200000.0 in Q4 2022 to a low of $43000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - |
| 10 | Pasithea Therapeutics | 14.75 Mn | 14.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2022 | 200,000.00 |
| Dec 31, 2022 | 200,000.00 |